Clinical Research Directory

Inclusion Criteria: 1. Age ≥ 18 years, gender unrestricted; 2. Clinically diagnosed with type 2 diabetes; 3. First-time treatment with metformin and empagliflozin tablets; 4. HbA1c test results within 2 weeks prior to enrollment (rapid fingertip test results are acceptable); 5. Voluntary participation in the study and signing of informed consent form. Exclusion Criteria: 1. Moderate to severe renal impairment (eGFR \< 45 mL/min/1.73 m²), end-stage renal disease, or dialysis; 2. Acute or chronic metabolic acidosis, including diabetic ketoacidosis; 3. A history of severe allergy to empagliflozin, metformin, or any excipient in this product; 4. Currently or within the past month, participation in any other clinical trials; 5. Judged by the investigator to be unsuitable for participation in this study.